You just read:

Liquid Biotech USA, Inc. Announces Completion of Proof-of-Concept (POC) Clinical Study that Triggers a $1M Milestone Payment from Oncolys Biopharma, Inc.

News provided by

Liquid Biotech USA, Inc.

Apr 05, 2016, 11:36 ET